BOHEMIA, N.Y.--(BUSINESS WIRE)--Advanced BioPhotonics Inc. (OTCBB: ABPH) a developer of next generation medical imaging applications using advanced infrared technology announced today that it has entered into an agreement with Beth Israel Deaconess Medical Center (BIDMC), a teaching hospital of Harvard Medical School. BIDMC will investigate the use of Advanced BioPhotonics’ proprietary DIRI® method of dynamic infrared imaging in detecting and assessing Pigmented Lesions of the Skin including Melanoma and other forms of Skin Cancer.